Al-Ghassani



 

[pic]

Apnea of Prematurity

Dharmendra J Nimavat, MD, FAAP, Assistant Professor of Clinical Pediatrics, Department of Pediatrics, Division of Neonatology, Southern Illinois University School of Medicine

Michael P Sherman, MD, Professor, Department of Child Health, University of Missouri-Columbia School of Medicine; Director, Fellowship Training Program in Neonatal-Perinatal Medicine, NICU, Columbia Regional Hospital; Professor Emeritus, Department of Pediatrics, University of California, Davis, School of Medicine; Rene L Santin, MD, Consulting Staff, Department of Pediatrics, Division of Neonatology, Primary Care Centers of Eastern Kentucky; Rachel Porat, MD, Director, Neonatal Apnea Monitoring Program, Assistant Director, Division of Neonatology, Albert Einstein Medical Center; Associate Professor, Department of Pediatrics, Thomas Jefferson University

Updated: Oct 26, 2009

Introduction

Background

Overview of the Current State of Knowledge

Our understanding of the anatomy, physiology, biochemistry, and molecular biology of neonatal breathing has increased in recent years.1, 2, 3, and 4 For instance, emerging data are elucidating the genes involved in the embryonic development of central respiratory centers and their neural networks.5 The central respiratory generator is essential for fetal breathing movements. It appears early in pregnancy and importantly contributes to pulmonary development.6

In the fetus, breathing is intermittent and occurs during the low-voltage electrocortical state (analogous to rapid eye movement [REM] sleep) and becomes continuous immediately after birth. The regulatory neurologic mechanisms that cause the transition from intermittent fetal breathing to continuous neonatal breathing are incompletely appreciated.7, 8

After birth, apnea of prematurity (AOP) is a major concern for caregivers in intensive care nurseries. The magnitude of this problem resulted in the National Institutes of Child Health and Human Development (NICHD) convening a workshop on apnea of prematurity. Summary Proceedings from the Apnea-of-Prematurity Group have been published.9

The NICHD review group emphasized the following conclusions:

• No consensus has been reached regarding the definition, diagnosis, or treatment of apnea of prematurity.

• Systematic research has not been conducted to investigate the value of different interventions for apnea of prematurity.

• Available technology is not routinely used to document real-time events associated with apnea.

• The time required to demonstrate an improvement in apnea of prematurity with a specific treatment has not been established.

• The observational period needed after therapy for apnea of prematurity is unknown, and an appropriate duration of surveillance off therapy is needed to reasonably prevent acute life-threatening events.

• Important confounding conditions that influence the occurrence of apnea of prematurity are poorly recognized and/or integrated into care.

• The relationship between gastroesophageal reflux (GER) and apnea of prematurity requires additional investigation because current knowledge suggests an infrequent association.

• Improved characterization of the effects of apnea of prematurity on neurodevelopment during infancy and childhood is needed.

• Other confounders associated with brain injury in preterm infants are difficult to separate from apnea of prematurity as meaningful causes of abnormal child development.

The NICHD review group also made recommendations about what issues associated with apnea of prematurity that need urgent attention, what research methods might be best for future studies, what outcomes are essential to our understanding of apnea of prematurity, and what ethical principles should govern future investigations of apnea of prematurity.

Given this discussion from the NICHD review group, the present article provides state-of-the-art information regarding what is and what is not known about apnea of prematurity.

Definitions

Apnea and its classification

Apnea is defined as the cessation of breathing for more than 20 seconds or apnea or the cessation of breathing for less than 20 seconds if it is accompanied by bradycardia or oxygen (O2) desaturation.10,9

• Bradycardia in a premature neonate is considered clinically significant when the heart rate slows by least 30 bpm from the resting heart rate.

• An O2 saturation level of more than 85% is considered pathologic in this age group, as is a decrease in O2 saturation should it persist for 5 seconds or longer.

These definitions represent clinically significant changes in apnea, bradycardia, and O2 saturation changes and rarely occur in healthy preterm neonates older than 36 weeks after conception.

Apnea is classified as central, obstructive, or mixed.

• Central apnea is defined as the cessation of both airflow and respiratory effort (see Media file 1).

[pic]

Central apnea is defined as the cessation of both airflow and respiratory effort. ECG = electrocardiogram; HR = heart rate; THO = thoracic impedance; FLOW = air flow; ACT = ; SpO2 = peripheral oxygen saturation; STAGE = sleep stage.

• Obstructive apnea is the cessation of airflow in the presence of continued respiratory effort.

• Mixed apnea contains elements of both central and obstructive apnea (see Media file 2), either within the same apneic pause or at different times during a period of respiratory recording.

[pic]

Polysomnogram. Mixed apnea contains elements of both central and obstructive apnea. ECG = electrocardiogram; HR = heart rate (bpm); THO = thoracic movement; FLOW = flow from the nose and mouth; ACT = gross body movement; SpO2 = peripheral oxygen saturation (%); STAGE = sleep stage, where AT = active sleep.

Apnea of infancy

Apnea of infancy (AOI) occurs when apnea persists in a neonate older than 37 weeks after conception. The physiologic aspects of apnea of prematurity and AOI coincide, though further studies are needed to determine their exact relationship.

Periodic breathing

Periodic breathing is defined as periods of regular respiration for as long as 20 seconds followed by apneic periods of 10 seconds or less that occur at least 3 times in succession (see Media file 3).

[pic]

Polysomnogram. Periodic breathing is defined as periods of regular respiration for as long as 20 seconds followed by apneic periods no longer than 10 seconds that occur at least 3 times in succession. ECG = electrocardiogram; HR = heart rate (bpm); THO = thoracic movement; FLOW = flow from the nose and mouth; ACT = gross body movement.

Periodic breathing may be observed for 2-6% of the breathing time in healthy term neonates and as much as 25% of the breathing time in preterm neonates. The occurrence of periodic breathing is directly proportional to the degree of prematurity.

Kelly and coworkers observed periodic breathing in 78% of neonates examined at 0-2 weeks of age.11 The incidence substantially declined to 29% at the postconceptual ages of 39-52 weeks.

Periodic breathing typically does not occur in neonates during their first 2 days of life.

Periodic breathing most frequently occurs during active sleep, but it can also happen when neonates are awake or quietly sleeping. This pattern, commonly observed in patients at high altitudes, is eliminated with supplemental oxygenation and/or with the use of continuous positive airway pressure (CPAP). Because the prognosis is excellent and because the infant is not compromised, no treatment is usually required.

Pathophysiology

Central respiratory regulation

Immaturity and/or depression of the central respiratory drive to the muscles of respiration have been accepted as key factors in the pathogenesis of apnea of prematurity.1 Vulnerability of the ventral surface of the medulla and adjacent areas in the brainstem to inhibitory mechanisms is the likely explanation for why apneic episodes occur in prematurely born infants. This vulnerability involves diverse clinicopathologic events.12,4 Inhibitory events that affect the central respiratory generator and initiate apnea include hypoxia, hyperthermia and adenosine secretion.13 Studies of preterm infants and in animals (especially genetically altered mice) have enhanced our understanding of the molecular and biochemical events leading to maturation of the central respiratory generator in preterm infants.2,3,14,15

Using noninvasive techniques, Henderson-Smart and coworkers documented that brainstem conduction times of auditory-evoked responses were longer in infants with apnea than in matched premature infants without apnea.16 This study elucidated apnea in preterm infants by indirectly showing that infants with apnea had greater-than-expected immaturity of brainstem function, which was based on postconceptional age. This finding supports the concept than an immature brainstem eventually develops control of breathing as dendritic spines and synaptic connections mature. An observation that emphasizes the importance of the central respiratory generator is the finding of increased apnea among preterm infants with bilirubin-encephalopathy diagnosed by using abnormal auditory brainstem-evoked responses.17

The absence of respiratory muscle activity during central apnea unequivocally implicates depression of respiratory center output. In support of this concept, Gauda and associates (1989) documented reduced electromyographic activity in the diaphragm during spontaneous obstructed inspiratory efforts.18 Such efforts characterize combined central and obstructive apnea.19 Therefore, episodes of both central and mixed apneic share an element of decreased respiratory center output to the respiratory muscles.

Sleep state and apnea

Apnea during infancy occurs most frequently during active or REM sleep.20,21 Apnea occurs relatively infrequently during quiet sleep, when respiration is characteristically regular, with little breath-to-breath variation in tidal volume and respiratory rate. However, periodic breathing may predominantly occur during non-REM sleep. During active sleep, respiration is mostly paradoxical due to spinal motoneural inhibition of the activity of intercostal muscles.22

In extremely preterm infants, the paucity of quiet sleep, together with an extremely compliant rib cage, makes paradoxical chest-wall movements almost a constant phenomenon. Paradoxical chest movement may predispose the baby to apnea by decreasing functional residual capacity (FRC) and limiting oxygenation.23

Chemoreceptors and mechanoreceptors

Complex relationships exist between respiratory control; several sites of central chemosensitivity to carbon dioxide (CO2) during sleep; and various neuromechanical factors originating in the lungs, chest wall, and upper airway that modify respiratory function during sleep.24

Responses of chemoreceptors in preterm and term neonates were recently reviewed.25,26,27 The response to elevated CO2 concentrations was blunted in prematurely born infants. This diminished response may partly be due to decreased central chemosensitivity or mechanical factors that prevent an adequate ventilatory response.28,29

The slope of the response curve for CO2 is decreased for preterm infants who have apnea.30 However, a cause-and-effect relationship between decreased CO2 responsiveness and apnea of prematurity has not been clearly established. Administration of CO2 ameliorates periodic breathing, but inhalation of CO2 is not a therapeutic option for human infants.

For many years, scientists have known that preterm infants respond to a decrease in inspired O2 concentration with a transient increase in ventilatory response, followed by return to baseline or even depression of ventilation.31 This response to low O2 in infants appears to result from initial stimulation of peripheral chemoreceptors then overriding depression of the respiratory center as a result of hypoxemia.32 Consistent with these findings is the observation that a progressive decrease in inspired O2 concentrations causes a significant flattening of CO2 responsiveness in preterm infants.33

This unstable response to low inspired O2 levels may play an important role in the origin of neonatal apnea. It offers a physiologic rationale for the decrease in incidence of apnea observed when a slightly increased concentration of inspired O2 is administered to infants with apnea.34

The Hering-Breuer reflex also plays an important role in modulating respiratory timing in human neonates. Pulmonary stretch receptors send an afferent neural input to brain and mediate the Hering-Breuer reflex by means of the vagus nerve. Thereafter, they inhibit inspiration, prolong expiration, or both, while increasing lung volume.23 Active shortening of expiratory duration with decreased lung volume may provide a breathing strategy for preserving FRC in a neonate with a highly compliant chest wall.

Upper airway obstruction substantially contributes to apneic episodes in preterm infants, and upper airway muscles show preferential reflex activation in response to airway obstruction in infants.35

Gerhardt and Bancalari compared the ability of preterm infants with and those without apnea to respond to end-expiratory airway occlusion.36,30 Prolongation of the occluded inspiratory effort was significantly prolonged in the group without apnea. This finding suggested that this group had a relatively mature respiratory reflex response that improved their ability to respond to airway obstruction.

In premature infants, complex changes in pulmonary mechanics and ventilatory timing accompany apnea.37 Before apnea occurs, total pulmonary resistance may increase in association with a decrease in tidal volume and prolongation of the expiratory time. Such changes have been noted before episodes of mixed, obstructive, and central apnea.

In 1982, Waggener and coworkers showed that a diminution in respiratory drive precedes apnea, a finding reminiscent of the cyclic alterations in respiratory drive.38 After apnea resolves and respiration resumes, the respiratory drive in premature infants initially increases, possibly because of a cumulative effect of hypoxia and hypercapnia. Total pulmonary and supraglottic resistance also increases, perhaps in response to a decrease in lung volume and collapse of the upper airway when respiratory drive declines during the apnea.

Of note, within 2 or 3 breaths after apnea, pulmonary resistance and respiratory drive is restored to normal pre-apnea values in premature infants. Therefore, the neural systems that restore respiratory homeostasis appear to be capable of mounting an adequate response, even in premature infants with apnea.

Upper airway instability and muscles of the chest wall

Premature infants have pharyngeal or laryngeal obstruction during spontaneous apnea.

Thach (1983) proposed a model in which the negative luminal pressures generated during inspiration in the upper airway predispose a compliant pharynx to collapse.39

Many muscles of the upper airway, especially the genioglossus muscles, have been widely implicated in mixed and obstructive apnea affecting both infants and adults. Carlo, Martin, and Difiore compared the activity of the genioglossus muscles with that of the diaphragm in response to hypercapnic stimulation.40 In preterm infants, genioglossus activation was delayed for about one minute after CO2 rebreathing was begun, and it occurred only after a CO2 threshold of approximately 45 mm Hg was reached.

In neonates inspiratory time is often modestly prolonged when end-expiratory airway occlusion prevents lung inflation. As indicated earlier, this effect is a manifestation of the Hering-Breuer reflex.

Studies in animals demonstrated that this vagally mediated inhibition of normal lung inflation has more influence on the upper airway muscles than on the diaphragm.41

Upper airway reflexes

The upper airway contains many sensory nerve endings that may respond to various chemical and mechanical stimuli. Sensory input from these upper airway receptors travels to the CNS by means of cranial nerves V, VI, IX, X, XI, and XII. They may strongly affect respiratory rate and rhythm, heart rate, and vascular resistance.42

The chemoreceptor drive may augment the ability of the upper airway muscles to respond to increasing negative pressure, whereas input from pulmonary stretch receptors inhibits it.43

Swallowing during the respiratory pause is unique to apnea and does not occur during periodic breathing.44

Effects of adenosine

Adenosine and its analogs cause respiratory depression.45 Adenosine antagonism is proposed as a mechanism to explain the therapeutic effect of aminophylline.46

Gastroesophageal reflux

GER and apnea are common in preterm infants. Because they often coexist, a lively and ongoing debate persists among healthcare professionals about the role of GER in apnea of prematurity.

An extensive literature review was undertaken to justify arguments about the role of GER in apnea of prematurity. Monitoring studies demonstrated that, when a relationship between reflux and apnea is observed, apnea may precede rather than follow reflux.47,48 During an apneic episode, loss of respiratory neural output may be accompanied by a decrease in lower esophageal tone, and GER occurs.

This phenomenon is supported by data from a newborn piglet model, which showed that hypoxia and apnea were accompanied by a reduction in lower esophageal sphincter pressure, which was a predisposing factor for GER.49

GER and apnea are also discussed in Differentials and in Special Concerns.

Frequency

United States

Although not always apparent, apnea of prematurity is the most common problem in premature neonates.9 Approximately 70% of babies born before 34 weeks of gestation have clinically significant apnea, bradycardia, or O2 desaturation during their hospital stay. The more immature the infant, the higher his or her risk of apnea of prematurity. Apnea may occur during the postnatal period in 25% of neonates who weighed less than 2500 g at birth and in 84% of neonates who weigh less than 1000 g.

Carlo and Barrington showed that apnea may begin on the first day of life in neonates without respiratory distress syndrome.50,51 However, apnea of prematurity is always a diagnosis of exclusion. Many diseases manifest with apnea on the day of birth; examples are intrapartum magnesium exposure, systemic infections or the fetal inflammatory response syndrome, pneumonia, intracranial pathology, seizures, hypoglycemia, and other metabolic disturbances.

Approximately 50% or more of surviving infants who weighed less than 1500 g at birth have episodes of apnea that must be managed with pharmacologic intervention or ventilatory support. Mixed apnea accounts for about 50% of all cases of apnea in premature neonates; about 40% are central apneas, and 10% are obstructive apneas.52 These percentages vary in different reports. In 50% of all apneic episodes, an obstructive component precedes or follows central apnea, which leads to mixed apnea.

International

To the authors' knowledge, no investigators have compared the incidence of apnea of prematurity in the United States with those of other countries.

Mortality/Morbidity

Butcher-Puech and coworkers found that infants in whom obstructive apnea exceeded 20 seconds had an increased incidence of intraventricular hemorrhage, hydrocephalus, prolonged mechanical ventilation, and abnormal neurologic development after their first year of life.53

In 1985, Perlman and Volpe described a decrease in the cerebral blood flow velocity that accompanies severe bradycardia (heart rate 40-50 mcg/mL is toxic

Interactions

Antagonizes actions of adenosine; may reduce clearance of theophylline by 25% and cause additive pharmacologic effects (decrease dose); additive positive inotropic and chronotropic effects may occur with beta-adrenergic agonists; cimetidine and fluconazole decrease clearance, increasing serum levels; phenytoin induces hepatic metabolism, decreasing half-life and increasing clearance; increases metabolism of phenobarbital and increases own metabolism

Incompatible with acyclovir, furosemide, lorazepam, oxacillin, and nitroglycerin

Solution compatible with 5% or 10% dextrose in water and normal saline

Terminal injection site compatible with dextrose and amino acid solutions, lipid emulsions, calcium gluconate, cefotaxime, cimetidine, clindamycin, dexamethasone, dobutamine, dopamine, epinephrine, fentanyl, gentamicin, heparin (180 bpm; functional cardiac symptoms (eg, extrasystoles) possible; restlessness and vomiting can be signs of toxicity; cholestatic hepatitis may prolong serum half-life

Follow-up

Further Inpatient Care

Apnea-free interval before discharge

Most neonatologists agree that babies should be apnea-free for 2-10 days before discharge. However, the interval between the last apneic event and a safe time for discharge is not clearly established. The minimum apnea-free period is debated among clinicians. Darnall et al concluded that otherwise healthy preterm neonates continue to have periods of apnea separated by as many as 8 days before the last episode of apnea before discharge.123 Infants with long intervals between apneic event often have risk factors other than apnea of prematurity (AOP).

Home monitoring

Home monitoring after discharge is necessary for infants whose apneic episodes continue despite the administration of methylxanthine. Infants undergoing methylxanthine therapy rarely are sent home without a monitor because apnea may recur after they outgrow their therapeutic level. Without a monitor, caregivers may not know when apnea reappears.

Some families cannot manage monitoring in the home. In these cases, the administration of caffeine may be the only possible therapy. Infants in this situation need frequent follow-up visits, and they should be readmitted for further evaluation when their blood levels approach the subtherapeutic range.

Further Outpatient Care

Home monitoring

Various agencies and organizations have stated that home monitoring cannot prevent sudden infant death syndrome (SIDS), also called crib death or cot death, in preterm infants who have apnea of prematurity during their hospitalization.10,9

Indications for home monitoring

Home monitoring may be indicated in the situations described below.

• Historical evidence suggests the occurrence of clinically significant apnea or an apparent life-threatening event (ALTE).

• Recording monitoring or multichannel evaluation documents apnea.

• The patient has gastroesophageal reflux (GER) with apnea.

• A sibling or twin of the patient died from SIDS or another postneonatal cause of death (see Special Concerns).

The National Institutes of Health (NIH) consensus conference recommends monitoring for the siblings of infants with SIDS, but only after 2 SIDS-related deaths occur in a family. Physicians often begin monitoring after one sibling dies from SIDS; this practice may be related to a fear of litigation should another child in the family die from SIDS. Siblings of patients who died from SIDS are routinely monitored until one month past the patient's age at death.

Monitoring is not indicated to prevent SIDS in infants older than one year, though proponents believe that such monitoring reduces anxiety in the parents of high-risk infants. Opponents of monitoring cite a lack of evidence to show that monitoring reduces the rate of SIDS. They argue that monitors intrude on the family's life and that they are poorly tolerated by the family.10

Types of monitors

Several types of cardiorespiratory monitors are available for home use in the United States. The most common type combines impedance pneumography with an assessment of the patient's mean heart rate. The most notable drawback of impedance monitors is their inability to detect obstructive apnea. Newer monitors can minimize false alarms caused by motion artifact.

Standard home monitors detect respiratory signals and heart rates. Electrodes are placed directly on the infant's chest or inside an adjustable belt secured around his or her chest.

Monitoring units should be capable of recording cardiac and respiratory data because this information can help the physician in evaluating the need to stop medication or monitoring. These devices also record compliance with monitor use. The event recorder contains a computer chip that continuously records respiratory and cardiac signals. Normal signals are erased, but any event that deviates from preset parameters activates the monitor to save records of that event, as well as data 15-75 before and 15-75 seconds it. Additional channels are available to record pulse oximetry readings, nasal airflow, and body position (eg, prone vs supine). The records are downloaded within 24 hours after a parent reports an event or after excessive alarms occur.

Many units now have computer modems that instantly transmit data to the physician's office for evaluation. These easily installed devices are especially useful for families who have had problems with events or alarms.

Some devices, such as pulse oximeters, piezo belts, and pressure capsules, have been impractical to use or have had limited applications. Newer technologies and software programs may soon make such oximeters and similar devices more practical than they once were.

All monitoring devices are associated with false alarms, which are alerts without in the absent of a true cardiorespiratory event. False alarms worry parents. If they happen often, they may discourage use of the monitor. Excessive false alarms can usually be minimized by adjusting the placement of the electrodes and by educating the parents.

Details of monitoring depend on the frequency of events observed during neonatal hospitalization, the size and stability of the infant at the time of discharge, and the degree of parental anxiety.

Follow-up of home monitoring and patient education

Careful follow-up is needed with all cases of home monitoring in prematurely born neonates. Physicians who have limited experience with home monitoring or who cannot interpret the downloaded recordings should seek assistance from a center or program with expertise in these areas.

The most important issue with monitoring is that Neonatal Resuscitation Program (NRP) instructors should educate parents, guardians, and other caregivers about neonatal resuscitation by using a mannequin before their child is discharged from the NICU.

Parents should also be educated about prenatal and postnatal factors associated with an increased risk of SIDS, namely, the following:124,26

• Prenatal and postnatal tobacco use

• Opiate abuse during pregnancy

• Baby's prone sleeping position

• Pacifier use

• Use of soft bedding

• Shared sleeping with children and adults

• Illnesses in infants with bronchopulmonary dysplasia

• Genetic factors

Parents must also be aware that postural skull deformities have occurred after the AAP offered positioning recommendations in its Back to Sleep campaign.125 Prematurely born infants are probably at increased risk. Ways to avoid or minimize skull deformities should be discussed with parents.

Parents of infants with home monitors must have a clearly designated person who they can contact on a regular basis and during emergencies. Many programs or centers provide 24-hour assistance for families of children with home monitors.

The mean duration of home monitoring for prematurely born neonates is often more than 6 weeks. Extended monitoring is reserved for infants whose recordings show notable cardiorespiratory abnormalities. Monitoring beyond age 1 year is uncommon. Most often, children who require such monitoring have other conditions that require the use of additional technology. An example is an infant with bronchopulmonary dysplasia who requires mechanical ventilation at home.

For infants who require therapy with a methylxanthine, drug therapy is typically stopped after 8 weeks without true events, but monitoring is continued for an additional 4 weeks.126,127 If no events are noted in this period, monitoring can be discontinued. These recommendations regarding discontinuing methylxanthines or home monitoring are not based on data from controlled studies; these investigations are badly needed.

Complications

Infants born prematurely are at increased risk for apnea and bradycardia after undergoing general anesthesia or sedation with ketamine, regardless of their history of apnea. Because of this increased risk, defer elective surgery, if possible, until approximately 52-60 weeks after conception to allow the infant's respiratory control mechanism to mature.

Prognosis

Regarding the natural history of apnea in infants born prematurely, the frequencies of all types of apnea gradually decreases during the first months of postnatal life. However, in some infants, apnea may persist until the age of 44 weeks after conception.

Patient Education

Family members and others involved in the care of an infant with apnea of prematurity should be well trained in cardiopulmonary resuscitation (CPR).

Many of the pitfalls of home monitoring can be avoided by providing 24-hour telephone access (the ideal level of service) to a designated physician or nurse who is involved in the infant's care. In addition to this access, families should receive frequent, regularly scheduled telephone calls from healthcare providers, as well as home visits by a nurse or respiratory technician or follow-up appointments in a clinic familiar with this field of care.

For excellent patient education resources, visit eMedicine's Children's Health Center. Also, see eMedicine's patient education article Sudden Infant Death Syndrome (SIDS).

Miscellaneous

Medicolegal Pitfalls

An Internet search of the terms preterm infant, sudden infant death syndrome (SIDS), and malpractice yields results linked to several law practices. Some of these sites tell parents that they should sue over the SIDS-related death of their preterm infant.

The medical literature is relatively silent about medical malpractice suits related to SIDS. The present authors know of malpractice cases involving infants who had apnea just days before discharge, who were discharged home without monitoring, and who then died at home or had an acute life-threatening event with brain injury. Even statements by national agencies that home monitoring cannot prevent SIDS have little impact when such malpractice cases go to a jury.

When an unanticipated death does occur at home, it must be properly investigated. The investigation should address the possibility of death from child abuse, as well as late deaths from unrecognized malformations or inborn errors of metabolism (eg, fatty acid oxidation disorders).128

Special Concerns

Controversies Related to Apnea of Prematurity

Use of car seats or car beds

The AAP has indicated that a car-seat challenge should be performed before preterm infants are discharged from the hospital.129 The importance of this testing is emphasized in an AAP pamphlet called Car Safety Seats: A Guide for Families 2007, which is given to parents. It addressed issues related to car-seat safety during infancy.

Adverse events do happen when preterm infants are placed in car seats.130 However, authors of a Cochrane Review could not conclude whether car-seat testing with preterm infants was beneficial or detrimental. They did conclude that additional research was needed to evaluate its effectiveness in preventing the complications of apnea.131

If problems are found, treatment is another matter. Some have thought that if a preterm infant does not pass a car-seat challenge, they can be safely transported in a car bed. However, Salhab et al reported that apnea and other adverse events were as likely to occur in car beds as in car seats.132 A preterm infant riding in a car seat should be carefully observed by a caregiver.

Retinal examinations

In NICUs, preterm infants have had apneic events after retinal examinations. Although the drugs used to dilate the iris are implicated in these apneic events, the incidence and mechanisms associated with apnea have been poorly studied.

Use of a pacifier

Another belief is that a preterm infant is at increased risk for SIDS if they suckle a pacifier. Researchers have concluded that the opposite is true.133 Moreover, pacifiers do not affect breastfeeding in preterm infants.134 Pacifiers should obviously be removed from the mouth of a sleeping supine infant.

Hypermagnesemia

Studies reported decades ago demonstrated that hypermagnesemia secondary to maternal magnesium sulfate administration can cause apnea immediately after birth.72 Some neonatologists do not agree with this finding.

Methylxanthine therapy

Prophylactic versus intent-to-treat use of methylxanthines is another controversial subject. Some suggest prophylactic use of methylxanthines is indicated when very preterm infants are extubated to discontinue assisted ventilation. Older infants with a history of apnea of prematurity (AOP) may also benefit from prophylactic methylxanthines if they must undergo anesthesia for a surgical procedure.

Likewise, prophylactic therapy with methylxanthines might seem reasonable in preterm infants with birth weights less than 1000 g. Nevertheless, use of methylxanthines in preterm infants are being viewed with caution because of their effects on brain development.

Substantial disagreement exists among neonatologists regarding the criteria for stopping methylxanthine therapy, such as the numbers of days without apnea, bradycardia, or desaturation that are required. The discontinuation of methylxanthines may also depends on the patient's postconceptual age and other factors in an individual infant. Neonatologists are conflicted about what is considered safe in terms of the number of event-free days after a methylxanthine is stopped and the number of days without apnea before hospital discharge. Additional clinical research is urgently needed to resolve these issues.

Use of caffeine versus aminophylline

Despite the relatively broad therapeutic index, the use of caffeine versus aminophylline to treat AOP is still an unsettled issue with some neonatologists.

Home monitoring

To the authors' knowledge, no protocols to determine when a preterm infant with apnea of prematurity should or should not have home monitoring have been evaluated in clinical trials.

Gastroesophageal reflux

Despite the overwhelming body of evidence that gastroesophageal reflux (GER) is not associated with apnea, many neonatologists still use agents to inhibit gastric acidity and thereby prevent apnea. This controversial issue in preterm infants with apnea of prematurity has been discussed throughout this article.

Sudden Infant Death Syndrome–Related Concerns

Possible risk factors for SIDS or near-miss SIDS

Infants born prematurely account for approximately 10% of the birth population, yet they experience slightly more than 20% of SIDS-related deaths. The immature respiratory control so commonly observed in premature neonates has led to suggestions of a relationship between apnea of prematurity and SIDS.

Premature infants in NICUs often cease breathing unexpectedly. These events are frequently accompanied by bradycardia and O2 desaturation. In many instances, the infant might not have resumed breathing without direct intervention.

The hypothesis that apnea is a cause of SIDS is attractive because the premature neonate does not struggle to resume breathing. This situation appears to be similar to that noted in many cases of SIDS. However, this theory of SIDS causation has not been proven. Furthermore, according to parental reports, most infants who died from SIDS were full-term neonates who had no apparent apneic events before death. However, visual detection of apnea and periodic breathing typically is difficult, even for medical personnel, and parents may miss such episodes.

No evidence identifies apnea of prematurity as an independent risk factor for SIDS, despite the ongoing controversy surrounding the relationship between apnea and SIDS. Despite all of their common factors, large-scale trials conducted to verify the relationship between apnea of prematurity and SIDS have failed to delineate an abnormality of ventilatory control that underlies SIDS.

Prolonged apnea has been reported in infants with near-miss SIDS (ie, infants who have had an apparent life-threatening event [ALTE]). Short episodes of apnea, periodic breathing, and mixed and obstructive apnea have been identified in infants with near-miss SIDS. These observations suggest that an abnormality in ventilatory control may contribute to SIDS. The risk of SIDS risk is highest among infants aged 2-4 months, similar to the risk for an ALTE. Positive family histories for these events are found for infants who die from SIDS and patients with apnea. Incidences of both conditions peak during cold weather months, and both typically occur while the infant is asleep.

A reduction in postneonatal mortality and SIDS rates have been associated with sleeping in a supine position rather than a prone position. Several research groups have documented physiologic benefits with prone positioning versus supine positioning in preterm infants; advantages included a modest improvement in transcutaneously measured PO2, prolonged time in quiet sleep, decreased energy expenditure, and increased ventilatory responses to inspired CO2. However, recent studies indicated that prone sleeping may increase the risk of SIDS after hospital discharge.135,136 The increased risk of SIDS appears related to fewer arousals and more central apnea with prone versus supine sleeping.

To decrease the incidence of SIDS, the AAP has recommended placing healthy neonates on their backs, instead of prone, for sleeping.124 The mechanism by which sleeping in the prone position can lead to SIDS is unclear.

In the Nordic Epidemiological SIDS study, Oyen et al concluded that sleeping in both the prone and side positions increased the risk of SIDS. In addition, side-lying sleep could result in prone sleep.137 The risk is further increased among low-birth-weight infants, infants born before term, and infants aged 13-24 weeks.

Soft bedding and shared sleeping are other factors related to SIDS. Posturing and cyanosis are often present, as is an increased incidence of prematurity, low birth weight, and evidence of poor prenatal care. Findings from epidemiologic studies suggest that as many as 18% of SIDS cases occur in infants who were born prematurely.

Polygraphic monitoring for SIDS

The aforementioned findings prompted the development of polygraphic monitoring to measure variables such as heart rate, nasal airflow, chest and abdominal movement, and transcutaneous O2 tension or O2 saturation to predict the risk for SIDS in vulnerable infants. A number of studies involving large cohorts of infants have not demonstrated that monitoring of cardiorespiratory variables can be used to prospectively identify infants at risk for SIDS.

At present, no simple and accurate method is available to predict whether a premature infant is likely to die from SIDS.

Home monitoring for SIDS

At present, home monitoring is conducted in more infants born prematurely than in any other pediatric population. Each year, perhaps as many as 15-20% of the 400,000 premature babies are treated with home cardiorespiratory monitoring, primarily to manage apnea but also to prevent SIDS.

Despite the number of premature infants receiving home monitoring, this therapy has not been embraced universally, and it remains controversial. Advocates believe that monitoring can alert caretakers to potentially serious episodes of apnea and/or bradycardia before they cause harm, helping parents to cope with the anxiety of caring for an infant born prematurely. Opponents cite the lack of evidence to indicate that monitoring alters the outcomes in any definable way. To the authors' knowledge, no prospective study has demonstrated that monitoring prevents SIDS. Furthermore, many physicians believe that the decision to use home monitoring places an emotional burden on parents.

Many programs have been developed to enable home cardiorespiratory monitoring of prematurely born neonates to reduce the rate of SIDS. However, to the authors' knowledge, no prospective randomized control study has been conducted to show that home cardiorespiratory monitoring prevents SIDS.

Anecdotal data from some programs suggest that the incidence of SIDS is lowered among premature neonates who are monitored extensively. However, the authors are aware of no data proving that home monitoring has caused this reduction in the incidence of SIDS.

Also unclear is whether this approach is a cost-effective adjunct to neonatal care. Even programs that have reduced the incidence of SIDS have reported deaths among the babies who were monitored. Moreover, the cost of hospitalization has increased to such an extent that the expense of a single inpatient day may be as costly as several months of home cardiorespiratory monitoring.

Ages of death

In term neonates, the acknowledged peak age of death from SIDS is 2-4 months, with a mean age of 52 weeks after conception. The peak age of death for the premature infant is approximately 4-6 months, but the mean age of 52 weeks after conception is the same. Therefore, a premature neonate may be at risk for SIDS for a long period after hospital discharge.

Little data are available regarding the comparative risks of SIDS among preterm neonates born at different postconceptional ages. The similarities in postconceptional ages of death for both term and preterm neonates suggests that a neurodevelopmental phenomenon may be among the etiologies of this as-yet unexplained problem.

SIDS prevention

Accumulating evidence from many countries indicates the importance of 2 factors for SIDS prevention in term infants:

1. Placing infants supine for sleeping

2. Preventing infants' exposure to cigarette smoke both during and after pregnancy

Unless clear contraindications are present, treat premature neonates in a similar manner. These interventions appear to reduce the incidence of SIDS far more than home monitoring does. However, in some clinical situations, monitoring may be valuable to treat apnea of prematurity and to help families cope with the discharge of a low-birth-weight infant.

Non–Sudden Infant Death Syndrome Monitoring Issues

Since the introduction of NICUs, preterm neonates have received an extraordinarily high level of medical support to compensate for various degrees of organ immaturity at birth. Unfortunately, the effectiveness of current NICU technology cannot begin to approach the combined effectiveness of placental circulation and maternal metabolism. As a result, some premature babies survive, with different degrees of injury to certain organ systems.

Bronchopulmonary dysplasia, cardiac disease, periventricular leukomalacia and other neurologic problems, and feeding difficulties are among the many problems that may require home monitoring for ongoing medical care. In these settings, monitoring appears valuable for alerting caretakers to any physiologic changes (eg, bradycardia, tachycardia, hypoxemia, seizures) that may require intervention.

Without home monitoring, many infants might be hospitalized unnecessarily. The emotional and financial costs associated with such hospitalization may be far greater than those borne if they child and family were at home. In such instances, home monitoring may be an effective and safe approach to medical care.

Home monitoring also may be an effective diagnostic tool for children whose events are so sporadic that they cannot be detected easily in the hospital. For example, newly developed monitoring devices can record abnormal events and can be used to detect and quantify infrequent episodes of apnea or ALTE, while helping to maintain a normal living situation for the child. If frequent events are detected, additional evaluation may be needed to identify a specific cause. Studies such as ECG, electroencephalography, cerebral imaging, and metabolic testing may be valuable in such instances.

Whether the use of monitoring devices and/or pharmacologic agents (eg, methylxanthines) reduces apnea and improves neurodevelopmental outcomes in infants born prematurely is unknown. Because of the complex nature of the infant's medical problems, the contribution of apnea to any developmental disability is difficult to estimate but was suggested in recent publications.56 Frequent apnea may adversely affect neurodevelopmental outcomes, especially when it is accompanied by bradycardia and O2 desaturation, and it should be reduced or prevented if possible.138

Neonatologists are aware of the parents' anxiety when they take their low-birth-weight infant home. With recent changes in inpatient care, many premature babies now leave the hospital with discharge weights of 1800-2000 g. Home monitoring may help such infants make the transition to their home setting. Again, carefully train all caretakers who will care for the infant at home. Include instruction in the use of the monitor and in how to perform cardiopulmonary resuscitation (CPR). Of course, inform parents that monitoring might not prevent SIDS.

References

1. Darnall RA, Ariagno RL, Kinney HC. The late preterm infant and the control of breathing, sleep, and brainstem development: a review. Clin Perinatol. Dec 2006;33(4):883-914; abstract x. [Medline].

2. Gaultier C, Gallego J. Development of respiratory control: evolving concepts and perspectives. Respir Physiol Neurobiol. Nov 15 2005;149(1-3):3-15. [Medline].

3. Gozal D. New concepts in abnormalities of respiratory control in children. Curr Opin Pediatr. Jun 2004;16(3):305-8. [Medline].

4. Martin RJ, Abu-Shaweesh JM. Control of breathing and neonatal apnea. Biol Neonate. 2005;87(4):288-95. [Medline].

5. Chatonnet F, Dominguez del Toro E, Thoby-Brisson M, et al. From hindbrain segmentation to breathing after birth: developmental patterning in rhombomeres 3 and 4. Mol Neurobiol. Dec 2003;28(3):277-94. [Medline].

6. Kotecha S. Lung growth for beginners. Paediatr Respir Rev. Dec 2000;1(4):308-13. [Medline].

7. Givan DC. Physiology of breathing and related pathological processes in infants. Semin Pediatr Neurol. Dec 2003;10(4):271-80. [Medline].

8. Sinha SK, Donn SM. Fetal-to-neonatal maladaptation. Semin Fetal Neonatal Med. Jun 2006;11(3):166-73. [Medline].

9. [Guideline] Finer NN, Higgins R, Kattwinkel J, Martin RJ. Summary proceedings from the apnea-of-prematurity group. Pediatrics. Mar 2006;117(3 Pt 2):S47-51. [Medline]. [Full Text].

10. American Academy of Pediatrics, Committee on Fetus and Newborn. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics. Apr 2003;111(4 Pt 1):914-7. [Medline]. [Full Text].

11. Kelly DH, Shannon DC. Periodic breathing in infants with near-miss sudden infant death syndrome. Pediatrics. Mar 1979;63(3):355-60. [Medline].

12. Martin RJ, Miller MJ, Carlo WA. Pathogenesis of apnea in preterm infants. J Pediatr. Nov 1986;109(5):733-41. [Medline].

13. Lagercrantz H. Improved understanding of respiratory control--implications for the treatment of apnoea. Eur J Pediatr. 1995;154(8 Suppl 3):S10-2. [Medline].

14. Putnam RW, Conrad SC, Gdovin MJ, et al. Neonatal maturation of the hypercapnic ventilatory response and central neural CO2 chemosensitivity. Respir Physiol Neurobiol. Nov 15 2005;149(1-3):165-79. [Medline].

15. Simakajornboon N, Kuptanon T. Maturational changes in neuromodulation of central pathways underlying hypoxic ventilatory response. Respir Physiol Neurobiol. Nov 15 2005;149(1-3):273-86. [Medline].

16. Henderson-Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brain-stem neural function in preterm infants. N Engl J Med. Feb 17 1983;308(7):353-7. [Medline].

17. Amin SB, Charafeddine L, Guillet R. Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants. J Perinatol. Jun 2005;25(6):386-90. [Medline].

18. Gauda EB, Miller MJ, Carlo WA, et al. Genioglossus and diaphragm activity during obstructive apnea and airway occlusion in infants. Pediatr Res. Dec 1989;26(6):583-7. [Medline].

19. Martin RJ, Abu-Shaweesh JM, Baird TM. Apnoea of prematurity. Paediatr Respir Rev. 2004;5 Suppl A:S377-82. [Medline].

20. Gould JB, Lee AF, James O, et al. The sleep state characteristics of apnea during infancy. Pediatrics. Feb 1977;59(2):182-94. [Medline].

21. Hoppenbrouwers T, Hodgman JE, Rybine D, et al. Sleep architecture in term and preterm infants beyond the neonatal period: the influence of gestational age, steroids, and ventilatory support. Sleep. Nov 1 2005;28(11):1428-36. [Medline].

22. Bryan AC, Bryan MH. Control of respiration in the newborn. Clin Perinatol. Sep 1978;5(2):269-81. [Medline].

23. Martin RJ, Okken A, Rubin D. Arterial oxygen tension during active and quiet sleep in the normal neonate. J Pediatr. Feb 1979;94(2):271-4. [Medline].

24. Krimsky WR, Leiter JC. Physiology of breathing and respiratory control during sleep. Semin Respir Crit Care Med. Feb 2005;26(1):5-12. [Medline].

25. Cohen G, Katz-Salamon M. Development of chemoreceptor responses in infants. Respir Physiol Neurobiol. Nov 15 2005;149(1-3):233-42. [Medline].

26. Hunt CE, Hauck FR. Sudden infant death syndrome. CMAJ. Jun 20 2006;174(13):1861-9. [Medline].

27. Koons A, Hegyi T, Mehta R, et al. Cerebral vascular responses to changes in carbon dioxide tension in term and preterm infants with apnea. Biol Neonate. 2003;84(2):115-8. [Medline].

28. Carlo WA, DiFiore JM. Respiratory muscle responses to changes in chemoreceptor drive in infants. J Appl Physiol. Mar 1990;68(3):1041-7. [Medline].

29. Noble LM, Carlo WA, Miller MJ, et al. Transient changes in expiratory time during hypercapnia in premature infants. J Appl Physiol. Mar 1987;62(3):1010-3. [Medline].

30. Gerhardt T, Bancalari E. Apnea of prematurity: II. Respiratory reflexes. Pediatrics. Jul 1984;74(1):63-6. [Medline].

31. Cross KW, Oppe TE. The effect of inhalation of high and low concentrations of oxygen on the respiration of the premature infant. J Physiol. May 1952;117(1):38-55. [Medline].

32. Gauda EB, McLemore GL, Tolosa J, et al. Maturation of peripheral arterial chemoreceptors in relation to neonatal apnoea. Semin Neonatol. Jun 2004;9(3):181-94. [Medline].

33. Rigatto H, De La Torre Verduzco R, Gates DB. Effects of O2 on the ventilatory response to CO2 in preterm infants. J Appl Physiol. Dec 1975;39(6):896-9. [Medline].

34. Simakajornboon N, Beckerman RC, Mack C, et al. Effect of supplemental oxygen on sleep architecture and cardiorespiratory events in preterm infants. Pediatrics. Nov 2002;110(5):884-8. [Medline].

35. Carlo WA, Miller MJ, Martin RJ. Differential response of respiratory muscles to airway occlusion in infants. J Appl Physiol. Sep 1985;59(3):847-52. [Medline].

36. Gerhardt T, Bancalari E. Apnea of prematurity: I. Lung function and regulation of breathing. Pediatrics. Jul 1984;74(1):58-62. [Medline].

37. Miller MJ, Petrie TG, Difiore JM. Changes in resistance and ventilatory timing that accompany apnea in premature infants. J Appl Physiol. Aug 1993;75(2):720-3. [Medline].

38. Waggener TB, Frantz ID 3rd, Stark AR, Kronauer RE. Oscillatory breathing patterns leading to apneic spells in infants. J Appl Physiol. May 1982;52(5):1288-95. [Medline].

39. Thach BT. The role of pharyngeal airway obstruction in prolonging infantile apneic spells. In: Tilden JT, Roeder JM, Steinschneide A, eds. Sudden Infant Death Syndrome. New York: Academic Press; 1983:279.

40. Carlo WA, Martin RJ, Difiore JM. Differences in CO2 threshold of respiratory muscles in preterm infants. J Appl Physiol. Dec 1988;65(6):2434-9. [Medline].

41. van Lunteren E, Strohl KP, Parker DM, et al. Phasic volume-related feedback on upper airway muscle activity. J Appl Physiol. Mar 1984;56(3):730-6. [Medline].

42. Harding R. Function of the larynx in the fetus and newborn. Annu Rev Physiol. 1984;46:645-59. [Medline].

43. Gauda EB, Carroll TP, Schwartz AR, et al. Mechano- and chemoreceptor modulation of respiratory muscles in response to upper airway negative pressure. J Appl Physiol. Jun 1994;76(6):2656-62. [Medline].

44. Miller MJ, DiFiore JM. A comparison of swallowing during apnea and periodic breathing in premature infants. Pediatr Res. Jun 1995;37(6):796-9. [Medline].

45. Zaidi SI, Jafri A, Martin RJ, Haxhiu MA. Adenosine A2A receptors are expressed by GABAergic neurons of medulla oblongata in developing rat. Brain Res. Feb 3 2006;1071(1):42-53. [Medline].

46. Darnall RA Jr. Aminophylline reduces hypoxic ventilatory depression: possible role of adenosine. Pediatr Res. Jul 1985;19(7):706-10. [Medline].

47. Arad-Cohen N, Cohen A, Tirosh E. The relationship between gastroesophageal reflux and apnea in infants. J Pediatr. Sep 2000;137(3):321-6. [Medline].

48. Peter CS, Sprodowski N, Bohnhorst B, et al. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics. Jan 2002;109(1):8-11. [Medline].

49. Kiatchoosakun P, Dreshaj IA, Abu-Shaweesh JM, et al. Effects of hypoxia on respiratory neural output and lower esophageal sphincter pressure in piglets. Pediatr Res. Jul 2002;52(1):50-5. [Medline].

50. Carlo WA, Martin RJ, Versteegh FG, et al. The effect of respiratory distress syndrome on chest wall movements and respiratory pauses in preterm infants. Am Rev Respir Dis. Jul 1982;126(1):103-7. [Medline].

51. Barrington KJ, Finer NN. Periodic breathing and apnea in preterm infants. Pediatr Res. Feb 1990;27(2):118-21. [Medline].

52. Finer NN, Barrington KJ, Hayes BJ, Hugh A. Obstructive, mixed, and central apnea in the neonate: physiologic correlates. J Pediatr. Dec 1992;121(6):943-50. [Medline].

53. Butcher-Puech MC, Henderson-Smart DJ, Holley D, et al. Relation between apnoea duration and type and neurological status of preterm infants. Arch Dis Child. Oct 1985;60(10):953-8. [Medline].

54. Perlman JM, Volpe JJ. Episodes of apnea and bradycardia in the preterm newborn: impact on cerebral circulation. Pediatrics. Sep 1985;76(3):333-8. [Medline].

55. Emancipator JL, Storfer-Isser A, Taylor HG, et al. Variation of cognition and achievement with sleep-disordered breathing in full-term and preterm children. Arch Pediatr Adolesc Med. Feb 2006;160(2):203-10. [Medline].

56. Janvier A, Khairy M, Kokkotis A, et al. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol. Dec 2004;24(12):763-8. [Medline].

57. Barrington KJ, Finer N, Li D. Predischarge respiratory recordings in very low birth weight newborn infants. J Pediatr. Dec 1996;129(6):934-40. [Medline].

58. Sola A, Chow L, Rogido M. Pulse oximetry in neonatal care in 2005. A comprehensive state of the art review [in Spanish]. An Pediatr (Barc). Mar 2005;62(3):266-81. [Medline].

59. Mayock DE. Apnea. Revised February 24, 2000. University of Washington Division of Neonatology Web site. NICU-WEB. Available at .

60. Di Fiore JM. Neonatal cardiorespiratory monitoring techniques. Semin Neonatol. Jun 2004;9(3):195-203. [Medline].

61. Gamble YD, Lutin WP, Mathew OP. Non-sinus bradyarrhythmias in very low birth weight infants. J Perinatol. Jan 2007;27(1):65-7. [Medline].

62. Menon AP, Schefft GL, Thach BT. Apnea associated with regurgitation in infants. J Pediatr. Apr 1985;106(4):625-9. [Medline].

63. Newell SJ, Booth IW, Morgan ME, et al. Gastro-oesophageal reflux in preterm infants. Arch Dis Child. Jun 1989;64(6):780-6. [Medline].

64. Khalaf MN, Porat R, Brodsky NL, Bhandari V. Clinical correlations in infants in the neonatal intensive care unit with varying severity of gastroesophageal reflux. J Pediatr Gastroenterol Nutr. Jan 2001;32(1):45-9. [Medline].

65. Andrade EO, Arain A, Malow BA. Partial epilepsy presenting as apneic seizures without posturing. Pediatr Neurol. Nov 2006;35(5):359-62. [Medline].

66. Robles P, Poblano A, Hernandez G, et al. Cortical, brainstem and autonomic nervous system dysfunction in infants with post-hemorrhagic hydrocephalus. Rev Invest Clin. Mar-Apr 2002;54(2):133-8. [Medline].

67. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. Jul 1998;17(7):593-8. [Medline].

68. Gonzalez BE, Mercado CK, Johnson L, et al. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med. 2003;31(1):60-8. [Medline].

69. Halasa NB, Williams JV, Wilson GJ, et al. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J. Dec 2005;24(12):1040-4. [Medline].

70. Rudd PT, Carrington D. A prospective study of chlamydial, mycoplasmal, and viral infections in a neonatal intensive care unit. Arch Dis Child. Feb 1984;59(2):120-5. [Medline].

71. Cheromcha DP, Hyman PE. Neonatal necrotizing enterocolitis. Inflammatory bowel disease of the newborn. Dig Dis Sci. Mar 1988;33(3 Suppl):78S-84S. [Medline].

72. Rasch DK, Huber PA, Richardson CJ, et al. Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr. Feb 1982;100(2):272-6. [Medline].

73. Ali A, Walentik C, Mantych GJ, et al. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports. Pediatrics. Jul 2003;112(1 Pt 1):e70-2. [Medline].

74. Westkamp E, Soditt V, Adrian S, et al. Blood transfusion in anemic infants with apnea of prematurity. Biol Neonate. 2002;82(4):228-32. [Medline].

75. [Best Evidence] Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. Jun 2005;115(6):1685-91. [Medline].

76. Armony-Sivan R, Eidelman AI, Lanir A, et al. Iron status and neurobehavioral development of premature infants. J Perinatol. Dec 2004;24(12):757-62. [Medline].

77. Kurth CD, Spitzer AR, Broennle AM, Downes JJ. Postoperative apnea in preterm infants. Anesthesiology. Apr 1987;66(4):483-8. [Medline].

78. Malviya S, Swartz J, Lerman J. Are all preterm infants younger than 60 weeks postconceptual age at risk for postanesthetic apnea?. Anesthesiology. Jun 1993;78(6):1076-81. [Medline].

79. Craven PD, Badawi N, Henderson-Smart DJ, O'Brien M. Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy. Cochrane Database Syst Rev. 2003;(3):CD003669. [Medline].

80. Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev. 2001;(3):CD000140. [Medline].

81. Pourcyrous M, Korones SB, Crouse D, Bada HS. Interleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants. Pediatrics. Mar 1998;101(3):E3. [Medline].

82. Ellison VJ, Davis PG, Doyle LW. Adverse reactions to immunization with newer vaccines in the very preterm infant. J Paediatr Child Health. Aug 2005;41(8):441-3. [Medline].

83. Pfister RE, Aeschbach V, Niksic-Stuber V, et al. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr. Jul 2004;145(1):58-66. [Medline].

84. Faldella G, Galletti S, Corvaglia L, et al. Safety of DTaP-IPV-HIb-HBV hexavalent vaccine in very premature infants. Vaccine. Jan 22 2007;25(6):1036-42. [Medline].

85. Lee J, Robinson JL, Spady DW. Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants. BMC Pediatr. 2006;6:20. [Medline].

86. Thach BT. Reflux associated apnea in infants: evidence for a laryngeal chemoreflex. Am J Med. Nov 24 1997;103(5A):120S-124S. [Medline].

87. Vermeylen D, Franco P, Hennequin Y, et al. Laryngeal oedema in neonatal apnoea and bradycardia syndrome (a pilot study). Early Hum Dev. Apr 2005;81(4):361-7. [Medline].

88. Jolley SG, Halpern CT, Sterling CE, Feldman BH. The relationship of respiratory complications from gastroesophageal reflux to prematurity in infants. J Pediatr Surg. Jul 1990;25(7):755-7. [Medline].

89. Justo RN, Gray PH. Fundoplication in preterm infants with gastro-oesophageal reflux. J Paediatr Child Health. Aug 1991;27(4):250-4. [Medline].

90. de Ajuriaguerra M, Radvanyi-Bouvet MF, Huon C, Moriette G. Gastroesophageal reflux and apnea in prematurely born infants during wakefulness and sleep. Am J Dis Child. Oct 1991;145(10):1132-6. [Medline].

91. Di Fiore JM, Arko M, Whitehouse M, et al. Apnea is not prolonged by acid gastroesophageal reflux in preterm infants. Pediatrics. Nov 2005;116(5):1059-63. [Medline].

92. Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnea in premature infants. J Pediatr. Mar 2001;138(3):355-60. [Medline].

93. Bohnhorst B, Gill D, Dordelmann M, et al. Bradycardia and desaturation during skin-to-skin care: no relationship to hyperthermia. J Pediatr. Oct 2004;145(4):499-502. [Medline].

94. Bohnhorst B, Heyne T, Peter CS, Poets CF. Skin-to-skin (kangaroo) care, respiratory control, and thermoregulation. J Pediatr. Feb 2001;138(2):193-7. [Medline].

95. Berterottiere D, D'Allest AM, Dehan M, Gaultier C. Effects of increase in body temperature on the breathing pattern in premature infants. J Dev Physiol. Jun 1990;13(6):303-8. [Medline].

96. Tirosh E, Bader D, Hodgins H, et al. Apnoea-associated heart rate changes among preterm and full-term infants exposed to hyperthermia. Clin Physiol. Jul 1998;18(4):331-5. [Medline].

97. Ludington-Hoe SM, Anderson GC, Swinth JY, et al. Randomized controlled trial of kangaroo care: cardiorespiratory and thermal effects on healthy preterm infants. Neonatal Netw. May-Jun 2004;23(3):39-48. [Medline].

98. Sontheimer D, Fischer CB, Scheffer F, et al. Pitfalls in respiratory monitoring of premature infants during kangaroo care. Arch Dis Child Fetal Neonatal Ed. Mar 1995;72(2):F115-7. [Medline].

99. Arnon SS, Midura TF, Clay SA, et al. Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA. May 2 1977;237(18):1946-51. [Medline].

100. Jeffery HE, Rahilly P, Read DJ. Multiple causes of asphyxia in infants at high risk for sudden infant death. Arch Dis Child. Feb 1983;58(2):92-100. [Medline].

101. Cademartiri F, Luccichenti G, Laganà F, et al. Effective clinical outcome of a mandibular distraction device using three-dimensional CT with volume rendering in Pierre-Robin sequence. Acta Biomed. Aug 2004;75(2):122-5. [Medline].

102. Denny A, Amm C. New technique for airway correction in neonates with severe Pierre Robin sequence. J Pediatr. Jul 2005;147(1):97-101. [Medline].

103. Wittenborn W, Panchal J, Marsh JL, et al. Neonatal distraction surgery for micrognathia reduces obstructive apnea and the need for tracheotomy. J Craniofac Surg. Jul 2004;15(4):623-30. [Medline].

104. Young TE, Mangum B. Methylxanthines. In: NeoFax. 19th ed. Raleigh, NC: Acorn; 2006:200-3.

105. [Best Evidence] Pantalitschka T, Sievers J, Urschitz MS, et al. Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. Jul 2009;94(4):F245-8. [Medline].

106. Millar D, Schmidt B. Controversies surrounding xanthine therapy. Semin Neonatol. Jun 2004;9(3):239-44. [Medline].

107. Schmidt B. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Biol Neonate. 2005;88(3):208-13. [Medline].

108. Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database Syst Rev. 2003;(1):CD000139. [Medline].

109. [Best Evidence] Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. May 18 2006;354(20):2112-21. [Medline].

110. Eichenwald EC, Howell RG 3rd, Kosch PC, et al. Developmental changes in sequential activation of laryngeal abductor muscle and diaphragm in infants. J Appl Physiol. Oct 1992;73(4):1425-31. [Medline].

111. Heyman E, Ohlsson A, Heyman Z, Fong K. The effect of aminophylline on the excursions of the diaphragm in preterm neonates. A randomized double-blind controlled study. Acta Paediatr Scand. Mar 1991;80(3):308-15. [Medline].

112. Chang J, Gray PH. Aminophylline therapy and cerebral blood flow velocity in preterm infants. J Paediatr Child Health. Apr 1994;30(2):123-5. [Medline].

113. Dani C, Bertini G, Reali MF, et al. Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment. Biol Neonate. Jul 2000;78(1):27-32. [Medline].

114. Pryds O, Schneider S. Aminophylline reduces cerebral blood flow in stable, preterm infants without affecting the visual evoked potential. Eur J Pediatr. Mar 1991;150(5):366-9. [Medline].

115. Robel-Tillig E, Vogtmann C. Aminophylline influences cerebral hyperperfusion after severe birth hypoxia. Acta Paediatr. Aug 2000;89(8):971-4. [Medline].

116. Rosenkrantz TS, Oh W. Aminophylline reduces cerebral blood flow velocity in low-birth-weight infants. Am J Dis Child. May 1984;138(5):489-91. [Medline].

117. Cikrit D, Mastandrea J, Grosfeld JL, et al. Significance of portal vein air in necrotizing entercolitis: analysis of 53 cases. J Pediatr Surg. Aug 1985;20(4):425-30. [Medline].

118. Cikrit D, Mastandrea J, West KW, et al. Necrotizing enterocolitis: factors affecting mortality in 101 surgical cases. Surgery. Oct 1984;96(4):648-55. [Medline].

119. Hufnal-Miller CA, Blackmon L, Baumgart S, Pereira GR. Enteral theophylline and necrotizing enterocolitis in the low-birthweight infant. Clin Pediatr (Phila). Nov 1993;32(11):647-53. [Medline].

120. Dani C, Bertini G, Pezzati M, et al. Brain hemodynamic effects of doxapram in preterm infants. Biol Neonate. 2006;89(2):69-74. [Medline].

121. Roll C, Horsch S. Effect of doxapram on cerebral blood flow velocity in preterm infants. Neuropediatrics. Apr 2004;35(2):126-9. [Medline].

122. Henderson-Smart D, Steer P. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev. 2004;(4):CD000074. [Medline].

123. Darnall RA, Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics. Nov 1997;100(5):795-801. [Medline].

124. American Academy of Pediatrics, Task Force on Sudden Infant Death Syndrome. The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. Nov 2005;116(5):1245-55. [Medline]. [Full Text].

125. [Guideline] Persing J, James H, Swanson J, Kattwinkel J. Prevention and management of positional skull deformities in infants. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine, Section on Plastic Surgery and Section on Neurological Surgery. Pediatrics. Jul 2003;112(1 Pt 1):199-202. [Medline].

126. Spitzer AR, Fox WW. Infant apnea. Pediatr Clin North Am. Jun 1986;33(3):561-81. [Medline].

127. Spitzer AR, Gibson E. Home monitoring. Clin Perinatol. Dec 1992;19(4):907-26. [Medline].

128. Hymel KP. Distinguishing sudden infant death syndrome from child abuse fatalities. Pediatrics. Jul 2006;118(1):421-7. [Medline].

129. Bull M, Agran P, Laraque D, et al. American Academy of Pediatrics. Committee on Injury and Poison Prevention. Safe transportation of newborns at hospital discharge. Pediatrics. Oct 1999;104(4 Pt 1):986-7. [Medline].

130. Ojadi VC, Petrova A, Mehta R, Hegyi T. Risk of cardio-respiratory abnormalities in preterm infants placed in car seats: a cross-sectional study. BMC Pediatr. 2005;5:28. [Medline].

131. Pilley E, McGuire W. Pre-discharge "car seat challenge" for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2006;(1):CD005386. [Medline].

132. Salhab WA, Khattak A, Tyson JE, et al. Car seat or car bed for very low birth weight infants at discharge home. J Pediatr. Mar 2007;150(3):224-8. [Medline].

133. Mitchell EA, Blair PS, L'Hoir MP. Should pacifiers be recommended to prevent sudden infant death syndrome?. Pediatrics. May 2006;117(5):1755-8. [Medline].

134. Collins CT, Ryan P, Crowther CA, et al. Effect of bottles, cups, and dummies on breast feeding in preterm infants: a randomised controlled trial. BMJ. Jul 24 2004;329(7459):193-8. [Medline].

135. Ariagno RL, van Liempt S, Mirmiran M. Fewer spontaneous arousals during prone sleep in preterm infants at 1 and 3 months corrected age. J Perinatol. May 2006;26(5):306-12. [Medline].

136. Bhat RY, Hannam S, Pressler R, et al. Effect of prone and supine position on sleep, apneas, and arousal in preterm infants. Pediatrics. Jul 2006;118(1):101-7. [Medline].

137. Oyen N, Markestad T, Skaerven R, et al. Combined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: the Nordic Epidemiological SIDS Study. Pediatrics. Oct 1997;100(4):613-21. [Medline].

138. Mattia FR, deRegnier RA. Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants. Pediatrics. Sep 1998;102(3):E35. [Medline].

139. Al-Matary A, Kutbi I, Qurashi M, et al. Increased peripheral chemoreceptor activity may be critical in destabilizing breathing in neonates. Semin Perinatol. Aug 2004;28(4):264-72. [Medline].

140. Brooks JG. Apparent life-threatening events and apnea of infancy. Clin Perinatol. Dec 1992;19(4):809-38. [Medline].

141. Chardon K, Bach V, Telliez F, et al. Effect of caffeine on peripheral chemoreceptor activity in premature neonates: interaction with sleep stages. J Appl Physiol. Jun 2004;96(6):2161-6. [Medline].

142. Chardon K, Telliez F, Bach V, et al. Effects of warm and cool thermal conditions on ventilatory responses to hyperoxic test in neonates. Respir Physiol Neurobiol. May 20 2004;140(2):145-53. [Medline].

143. Decker MJ, Rye DB. Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning. Sleep Breath. Dec 2002;6(4):205-10. [Medline].

144. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. Sep 1997;100(3 Pt 1):354-9. [Medline].

145. Gewolb IH, Vice FL. Abnormalities in the coordination of respiration and swallow in preterm infants with bronchopulmonary dysplasia. Dev Med Child Neurol. Jul 2006;48(7):595-9. [Medline].

146. Gewolb IH, Vice FL. Maturational changes in the rhythms, patterning, and coordination of respiration and swallow during feeding in preterm and term infants. Dev Med Child Neurol. Jul 2006;48(7):589-94. [Medline].

147. Henderson-Smart DJ, Butcher-Puech MC, Edwards DA. Incidence and mechanism of bradycardia during apnoea in preterm infants. Arch Dis Child. Mar 1986;61(3):227-32. [Medline].

148. Henderson-Smart DJ, Ponsonby AL, Murphy E. Reducing the risk of sudden infant death syndrome: a review of the scientific literature. J Paediatr Child Health. Jun 1998;34(3):213-9. [Medline].

149. Henderson-Smart DJ, Steer P. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. Cochrane Database Syst Rev. 2001;(4):CD000048. [Medline].

150. Herschel M, Mittendorf R. Tocolytic magnesium sulfate toxicity and unexpected neonatal death. J Perinatol. Jun 2001;21(4):261-2. [Medline].

151. Hunt CE. Ontogeny of autonomic regulation in late preterm infants born at 34-37 weeks postmenstrual age. Semin Perinatol. Apr 2006;30(2):73-6. [Medline].

152. Khan A, Qurashi M, Kwiatkowski K, et al. Measurement of the CO2 apneic threshold in newborn infants: possible relevance for periodic breathing and apnea. J Appl Physiol. Apr 2005;98(4):1171-6. [Medline].

153. Kugelman A, Bilker A, Bader D, et al. Sidestream end-tidal capnometry as related to infant's position and maturation. Acta Paediatr. 2002;91(8):869-73. [Medline].

154. Lipsky CL, Gibson E, Cullen JA, et al. The timing of SIDS deaths in premature infants in an urban population. Clin Pediatr (Phila). Aug 1995;34(8):410-4. [Medline].

155. Martin RJ, Okken A, Katona PG, Klaus MH. Effect of lung volume on expiratory time in the newborn infant. J Appl Physiol. Jul 1978;45(1):18-23. [Medline].

156. Molloy EJ, Di Fiore JM, Martin RJ. Does gastroesophageal reflux cause apnea in preterm infants?. Biol Neonate. 2005;87(4):254-61. [Medline].

157. Perlman JM. Brain injury in the term infant. Semin Perinatol. Dec 2004;28(6):415-24. [Medline].

158. Pichler G, Urlesberger B, Müller W. Impact of bradycardia on cerebral oxygenation and cerebral blood volume during apnoea in preterm infants. Physiol Meas. Aug 2003;24(3):671-80. [Medline].

159. Razi NM, DeLauter M, Pandit PB. Periodic breathing and oxygen saturation in preterm infants at discharge. J Perinatol. Sep 2002;22(6):442-4. [Medline].

160. Rigatto H. Maturation of breathing. Clin Perinatol. Dec 1992;19(4):739-56. [Medline].

161. Rigatto H, Brady JP. Periodic breathing and apnea in preterm infants. I. Evidence for hypoventilation possibly due to central respiratory depression. Pediatrics. Aug 1972;50(2):202-18. [Medline].

162. Sanchez PJ, Laptook AR, Fisher L, et al. Apnea after immunization of preterm infants. J Pediatr. May 1997;130(5):746-51. [Medline].

163. Sawnani H, Jackson T, Murphy T, et al. The effect of maternal smoking on respiratory and arousal patterns in preterm infants during sleep. Am J Respir Crit Care Med. Mar 15 2004;169(6):733-8. [Medline].

164. Southall DP, Levitt GA, Richards JM, et al. Undetected episodes of prolonged apnea and severe bradycardia in preterm infants. Pediatrics. Oct 1983;72(4):541-51. [Medline].

165. Stefano JL, Anday EK, Davis JM, et al. Pneumograms in premature infants: a study of longitudinal data. Am J Perinatol. May 1991;8(3):170-3. [Medline].

166. Tamim H, Khogali M, Beydoun H, et al. Consanguinity and apnea of prematurity. Am J Epidemiol. Nov 15 2003;158(10):942-6. [Medline].

167. Yamamoto A, Yokoyama N, Yonetani M, et al. Evaluation of change of cerebral circulation by SpO2 in preterm infants with apneic episodes using near infrared spectroscopy. Pediatr Int. Dec 2003;45(6):661-4. [Medline].

Keywords

apnea of prematurity, AOP, fetal breathing, pathologic apnea, central apnea, obstructive apnea, mixed apnea, apnea of infancy, AOI, neonatal apnea, sudden infant death syndrome, SIDS, crib death, cot death

Contributor Information and Disclosures

Author

Dharmendra J Nimavat, MD, FAAP, Assistant Professor of Clinical Pediatrics, Department of Pediatrics, Division of Neonatology, Southern Illinois University School of Medicine

Dharmendra J Nimavat, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics and American Association of Physicians of Indian Origin

Disclosure: Nothing to disclose.

Coauthor(s)

Michael P Sherman, MD, Professor, Department of Child Health, University of Missouri-Columbia School of Medicine; Director, Fellowship Training Program in Neonatal-Perinatal Medicine, NICU, Columbia Regional Hospital; Professor Emeritus, Department of Pediatrics, University of California, Davis, School of Medicine

Michael P Sherman, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, European Society for Paediatric Research, Perinatal Research Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Rene L Santin, MD, Consulting Staff, Department of Pediatrics, Division of Neonatology, Primary Care Centers of Eastern Kentucky

Disclosure: Nothing to disclose.

Rachel Porat, MD, Director, Neonatal Apnea Monitoring Program, Assistant Director, Division of Neonatology, Albert Einstein Medical Center; Associate Professor, Department of Pediatrics, Thomas Jefferson University

Rachel Porat, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Medical Editor

Steven M Donn, MD, Professor of Pediatrics, University of Michigan Medical School; Director, Division of Neonatal-Perinatal Medicine, Department of Pediatrics, CS Mott Children's Hospital, University of Michigan Health System

Steven M Donn, MD is a member of the following medical societies: American Pediatric Society

Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine

Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Arun K Pramanik, MD, MBBS, Professor of Pediatrics, Director of Neonatal Fellowship, Louisiana State University Health Sciences Center

Arun K Pramanik, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, National Perinatal Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

CME Editor

Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina

Carol L Wagner, MD is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American Medical Women's Association, American Public Health Association, American Society for Bone and Mineral Research, American Society for Clinical Nutrition, Massachusetts Medical Society, National Perinatal Association, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD, Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Pediatric Society, Connecticut State Medical Society, Eastern Society for Pediatric Research, and Society for Pediatric Research

Disclosure: Nothing to disclose.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download